MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.pnpbp.2025.111473

Медицинская библиотека · Progress in neuro-psychopharmacology & biological psychiatry · 2025

Dual role of Interleukin-18 in linking metabolic and psychiatric symptoms: Insights from machine learning in schizophrenia.

Chai Yali, Xia Qingrong, Cheng Jian, Yan Junwei, Li Chao, Kong Xiaoming, Hu Jiayi, Gao Jianliang, Zhang Loufeng, Ju Peijun, Zhu Cuizhen

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Interleukin-18 (IL-18) has been implicated in both metabolic syndrome (MetS) and schizophrenia, but its dual role in their comorbidity remains unclear. This study aimed to explore how IL-18 interacts with metabolic and psychiatric aspects in this context. We recruited 146 participants divided into three groups: MetS (n = 48), non-MetS (n = 54), and healthy controls (n = 44). Psychiatric symptoms were assessed using the Positive and Negative Syndrome Scale, while biochemical parameters were measured via an automatic biochemistry analyzer. Levels of 14 cytokines/chemokines, including IL-4, IL-8, IL-10, IL-13, IL-18, and Eotaxin were detected using Meso Scale Discovery (MSD) technology. Linear regression and Gradient Boosting Machine (GBM) models revealed that IL-18 significantly impacted metabolic indices (e.g., triglycerides, waist circumference, BMI) and psychiatric symptoms (e.g., psychopathology score, aggressiveness score, PANSS total score) in the MetS group. Analysis using Partial Dependence Plots (PDP) and Accumulated Local Effects (ALE) plots revealed that IL-18 had complex, non-linear interactions with metabolic markers and clinical symptoms. To further elucidate the comprehensive effects of IL-18 on metabolism and symptoms, we integrated these markers into two overarching domains: metabolic and symptomatic. Extreme Gradient Boosting (XGBoost) regression models and SHapley Additive exPlanations (SHAP) values were then employed to quantify the influence of IL-18 on these domains. Results indicated that IL-18's impact on clinical symptoms was more pronounced at lower levels, diminishing as its concentration increased, while its metabolic impact was more significant at higher levels. This study highlights IL-18's dual role as an inflammatory bridge between metabolic dysregulation and psychopathology in comorbidity and underscores the need for further investigation into the underlying mechanisms driving these non-linear interactions.

Для цитирования: Chai Yali, Xia Qingrong, Cheng Jian, Yan Junwei, Li Chao, Kong Xiaoming, Hu Jiayi, Gao Jianliang, Zhang Loufeng, Ju Peijun, Zhu Cuizhen. Dual role of Interleukin-18 in linking metabolic and psychiatric symptoms: Insights from machine learning in schizophrenia.. Progress in neuro-psychopharmacology & biological psychiatry. 2025. DOI: 10.1016/j.pnpbp.2025.111473.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.